Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.38 |
| ▸ | ACP3 | P15309 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1827511 | 0.89 | LMNA (0.42) | MAPTALDH1A1CYP2D6FFAR1 | |
| SCHEMBL13616887 | 0.89 | LMNA (0.42) | MAPTALDH1A1CYP2D6FFAR1 | |
| SCHEMBL4670365 | 0.80 | ALDH1A1 (0.37) | ALDH1A1CYP2D6CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL10071710 | 0.79 | AOC3 (0.41) | SLC6A9MAPTALDH1A1CYP2D6CYP2C9 | |
| Nitrobenzene SCHEMBL28169232 | 0.76 | ALDH1A1 (0.47) | MAPTALDH1A1CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL4669959 | 0.75 | AOC3 (0.39) | MAPTALDH1A1CYP2D6CYP2C19SMN1; SMN2 | |
| SCHEMBL8698887 | 0.73 | MME (0.46) | ACP3 | |
| SCHEMBL2634575 | 0.73 | PTGS2 (0.46) | PTGS2MAPTSMN1; SMN2L3MBTL1UTS2R | |
| SCHEMBL13349804 | 0.73 | KDM4E (0.55) | PTGS2ALDH1A1SMN1; SMN2FFAR1 | |
| SCHEMBL28096818 | 0.73 | ACP3 (0.40) | PTGS2CHRNB2CHRNA4CYP17A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6927290-B2 | Production of mixed acid anhydride and amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-08-09 | — | — | US | disclosed |
| EP-1160236-B1 | Production of mixed acid anhydride and amine compound | SUMITOMO CHEMICAL CO (JP) | 2005-05-25 | — | — | EP | disclosed |
| US-20040210059-A1 | Production of mixed acid anhydride and amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-10-21 | — | — | US | disclosed |
| EP-1160236-A2 | Production of mixed acid anhydride and amine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040210059-A1 | Production of mixed acid anhydride and amide compound | CA2, CA1, CA3 | PTGS2 1726/4885CHRNB2 1191/4885CHRNA4 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.